These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 26088929)
21. MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia. Zeng CW; Chen ZH; Zhang XJ; Han BW; Lin KY; Li XJ; Wei PP; Zhang H; Li Y; Chen YQ Autophagy; 2014 Oct; 10(10):1726-37. PubMed ID: 25126724 [TBL] [Abstract][Full Text] [Related]
22. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Grisolano JL; Wesselschmidt RL; Pelicci PG; Ley TJ Blood; 1997 Jan; 89(2):376-87. PubMed ID: 9002938 [TBL] [Abstract][Full Text] [Related]
24. The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability. Yang WC; Shih HM Oncogene; 2013 Oct; 32(43):5167-75. PubMed ID: 23208507 [TBL] [Abstract][Full Text] [Related]
25. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. Duprez E; Wagner K; Koch H; Tenen DG EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978 [TBL] [Abstract][Full Text] [Related]
26. Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia. Chen Z; Tong Y; Li Y; Gao Q; Wang Q; Fu C; Xia Z PLoS One; 2015; 10(3):e0122530. PubMed ID: 25815789 [TBL] [Abstract][Full Text] [Related]
27. Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA mice. Wartman LD; Welch JS; Uy GL; Klco JM; Lamprecht T; Varghese N; Nagarajan R; Ley TJ PLoS One; 2012; 7(10):e46529. PubMed ID: 23056333 [TBL] [Abstract][Full Text] [Related]
28. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype. Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072 [TBL] [Abstract][Full Text] [Related]
29. Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: Focus on DNA repair genes. Casorelli I; Tenedini E; Tagliafico E; Blasi MF; Giuliani A; Crescenzi M; Pelosi E; Testa U; Peschle C; Mele L; Diverio D; Breccia M; Lo-Coco F; Ferrari S; Bignami M Leukemia; 2006 Nov; 20(11):1978-88. PubMed ID: 16990782 [TBL] [Abstract][Full Text] [Related]
30. PML-RARA fusion resulting from a cryptic insertion of RARA gene into PML gene without the reciprocal RARA-PML fusion: clinical, cytogenetic, and molecular characterization and prognosis. Fan H; Ortega V; Fanasch HM; Wang Y; Holder KN; Higgins RA; Mendiola C; Mohamed G; Vadlamudi K; Velagaleti G Eur J Haematol; 2014 Oct; 93(4):354-8. PubMed ID: 24673420 [TBL] [Abstract][Full Text] [Related]
31. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction]. Lang L; Li HM; Liu H; Wang YM; Zhang XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789 [TBL] [Abstract][Full Text] [Related]
32. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA. Keeshan K; Vieugué P; Chaudhury S; Rishi L; Gaillard C; Liang L; Garcia E; Nakamura T; Omidvar N; Kogan SC Haematologica; 2016 Oct; 101(10):1228-1236. PubMed ID: 27390356 [TBL] [Abstract][Full Text] [Related]
33. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355 [TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic proteins regulate differentiation of human promyelocytic leukemia cells. Topić I; Ikić M; Ivčević S; Kovačić N; Marušić A; Kušec R; Grčević D Leuk Res; 2013 Jun; 37(6):705-12. PubMed ID: 23528261 [TBL] [Abstract][Full Text] [Related]
35. PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity. Noguera NI; Piredda ML; Taulli R; Catalano G; Angelini G; Gaur G; Nervi C; Voso MT; Lunardi A; Pandolfi PP; Lo-Coco F Oncotarget; 2016 Oct; 7(41):66386-66397. PubMed ID: 27626703 [TBL] [Abstract][Full Text] [Related]
36. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Guibal FC; Alberich-Jorda M; Hirai H; Ebralidze A; Levantini E; Di Ruscio A; Zhang P; Santana-Lemos BA; Neuberg D; Wagers AJ; Rego EM; Tenen DG Blood; 2009 Dec; 114(27):5415-25. PubMed ID: 19797526 [TBL] [Abstract][Full Text] [Related]
37. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway. Chen ZH; Wang WT; Huang W; Fang K; Sun YM; Liu SR; Luo XQ; Chen YQ Cell Death Differ; 2017 Feb; 24(2):212-224. PubMed ID: 27740626 [TBL] [Abstract][Full Text] [Related]
38. PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells. Fang Y; Garnier D; Lee TH; D'Asti E; Montermini L; Meehan B; Rak J Angiogenesis; 2016 Jan; 19(1):25-38. PubMed ID: 26374632 [TBL] [Abstract][Full Text] [Related]